Invention Grant
- Patent Title: Uses
-
Application No.: US16219589Application Date: 2018-12-13
-
Publication No.: US10682355B2Publication Date: 2020-06-16
- Inventor: Lawrence P. Wennogle
- Applicant: INTRA-CELLULAR THERAPIES, INC.
- Applicant Address: US NY New York
- Assignee: INTRA-CELLULAR THERAPIES, INC.
- Current Assignee: INTRA-CELLULAR THERAPIES, INC.
- Current Assignee Address: US NY New York
- Agency: Hoxie & Associates LLC
- Main IPC: A61K31/519
- IPC: A61K31/519 ; A61P25/16 ; A61P25/14 ; A61P25/28 ; A61P25/02 ; A61K31/527 ; A61K31/53 ; A61K31/517 ; G01N33/84
Abstract:
The subject matter generally relates to methods of treatment and/or prophylaxis of CNS diseases, disorders, and/or injuries. In one aspect, the subject matter relates to inhibitors of phosphodiesterase 1 (PDE1) as neuroprotective agents and/or neural regenerative agents. In a further aspect, the subject matter relates to individuals that are at risk for the development of CNS disease or disorder.
Public/Granted literature
- US20190192519A1 NOVEL USES Public/Granted day:2019-06-27
Information query
IPC分类:
